Williams David G A, Ohnuma Tetsu, Krishnamoorthy Vijay, Raghunathan Karthik, Sulo Suela, Cassady Bridget A, Hegazi Refaat, Wischmeyer Paul E
CAPER Unit, Department of Anesthesiology, Duke University School of Medicine, DUMC, Box 3094 Mail # 41, 2301 Erwin Road, 5692 HAFS, Durham, NC 27710 USA.
Duke Clinical Research Institute, Durham, NC USA.
Perioper Med (Lond). 2020 Oct 5;9:29. doi: 10.1186/s13741-020-00160-6. eCollection 2020.
Small randomized trials of early postoperative oral nutritional supplementation (ONS) suggest various health benefits following colorectal surgery (CRS). However, real-world evidence of the impact of early ONS on clinical outcomes in CRS is lacking.
Using a nationwide administrative-financial database (Premier Healthcare Database), we examined the association between early ONS use and postoperative clinical outcomes in patients undergoing elective open or laparoscopic CRS between 2008 and 2014. Early ONS was defined as the presence of charges for ONS before postoperative day (POD) 3. The primary outcome was composite infectious complications. Key secondary efficacy (intensive care unit (ICU) admission and gastrointestinal complications) and falsification (blood transfusion and myocardial infarction) outcomes were also examined. Propensity score matching was used to assemble patient groups that were comparable at baseline, and differences in outcomes were examined.
Overall, patients receiving early ONS were older with greater comorbidities and more likely to be Medicare beneficiaries with malnutrition. In a well-matched sample of early ONS recipients ( = 267) versus non-recipients ( = 534), infectious complications were significantly lower in early ONS recipients (6.7% vs. 11.8%, < 0.03). Early ONS use was also associated with significantly reduced rates of pneumonia ( < 0.04), ICU admissions ( < 0.04), and gastrointestinal complications ( < 0.05). There were no significant differences in falsification outcomes.
Although early postoperative ONS after CRS was more likely to be utilized in elderly patients with greater comorbidities, the use of early ONS was associated with reduced infectious complications, pneumonia, ICU admission, and gastrointestinal complications. This propensity score-matched study using real-world data suggests that clinical outcomes are improved with early ONS use, a simple and inexpensive intervention in CRS patients.
早期术后口服营养补充(ONS)的小型随机试验表明,结直肠手术(CRS)后有多种健康益处。然而,缺乏早期ONS对CRS临床结局影响的真实世界证据。
利用全国性行政财务数据库(Premier Healthcare Database),我们研究了2008年至2014年间接受择期开放或腹腔镜CRS患者早期ONS使用与术后临床结局之间的关联。早期ONS定义为术后第3天(POD)前有ONS费用。主要结局是复合感染并发症。还检查了关键的次要疗效(重症监护病房(ICU)入院和胃肠道并发症)和伪造结局(输血和心肌梗死)。倾向评分匹配用于组建基线可比的患者组,并检查结局差异。
总体而言,接受早期ONS的患者年龄较大,合并症更多,更有可能是患有营养不良的医疗保险受益人。在早期ONS接受者(n = 267)与非接受者(n = 534)的良好匹配样本中,早期ONS接受者的感染并发症显著更低(6.7%对11.8%,P < 0.03)。早期ONS的使用还与肺炎发生率显著降低(P < 0.04)、ICU入院率显著降低(P < 0.04)和胃肠道并发症显著降低(P < 0.05)相关。伪造结局无显著差异。
尽管CRS术后早期ONS更有可能在合并症更多的老年患者中使用,但早期ONS的使用与感染并发症、肺炎、ICU入院和胃肠道并发症的减少相关。这项使用真实世界数据的倾向评分匹配研究表明,早期ONS的使用可改善临床结局,这是一种对CRS患者简单且廉价的干预措施。